You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

yh003

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Beijing (YH003)

Recruiting
  • Advanced Solid Tumors
  • YH003
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 2, 2022

Solid Tumor Trial in Australia (YH003, YH001, Pembrolizumab)

Recruiting
  • Solid Tumor
  • YH003
  • +2 more
  • Blacktown, New South Wales, Australia
  • +3 more
Apr 6, 2022

Mucosal Melanoma Trial in China (YH003, Pembrolizumab, albumin paclitaxel)

Recruiting
  • Mucosal Melanoma
  • YH003
  • +2 more
  • Fuzhou, Fujian, China
  • +11 more
Oct 8, 2022

Melanoma, Pancreatic Ductal Adenocarcinoma Trial in Richmond (YH003, Toripalimab, Nab-paclitaxel)

Recruiting
  • Melanoma
  • Pancreatic Ductal Adenocarcinoma
  • YH003
  • +3 more
  • Richmond, Victoria, Australia
    Epworth Medical Centre
Dec 22, 2021

Advanced Solid Tumors Trial in Nedlands (YH003, Toripalimab, Nab-paclitaxel)

Active, not recruiting
  • Advanced Solid Tumors
  • YH003
  • +3 more
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Dec 29, 2021